Use of the BOADICEA Web Application in clinical practice: appraisals by clinicians from various countries Anne Brédart, Jean-Luc Kop, Antonis C. Antoniou, Alex P. Cunningham, Antoine De Pauw, Marc Tischkowitz, Hans Ehrencrona, Sylvie Dolbeault, Lénore Robieux, Kerstin Rhiem, Douglas F. Easton, Peter Devilee, Dominique Stoppa-Lyonnet, Rita Schmutlzer; doi: 10.1007/s10689-017-0014-x
Patient-Centered Care in Breast Cancer Genetic Clinics Anne Brédart, Amélie Anota, Julia Dick, Violetta Kuboth, Olivier Lareyre, Antoine De Pauw, Alejandra Cano, Dominique Stoppa-Lyonnet, Rita Schmutzler, Sylvie Dollbeault, and Jean-Luc Kop; doi: 10.3390/ijerph15020319
Inherited mutations in BRCA1 and BRCA2 in an unselected multiethnic cohort of Asian patients with breast cancer and healthy controls from Malaysia Wei Xiong Wen, Jamie Allen, Kah Nyin Lai, et. al.; doi: 10.1136/jmedgenet-2017-104947
Association analysis identifies 65 new breast cancer risk loci
Kyriaki Michailidou, Sara Lindström et.al.; doi:10.1038/nature24284
Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer Roger L Milne, Karoline B Kuchenbaecker et. al.; doi:10.1038/ng.3785
pedigreejs: a web-based graphical pedigree editor Tim Carver, Alex P. Cunningham et.al.; doi: 10.1093/bioinformatics/btx705
Clinicians’ use of breast cancer risk assessment tools according to their perceived importance of breast cancer risk factors: an international survey Anne Brédart, Jean-Luc Kop, Antonis C. Antoniou et.al.; doi: 10.1007/s12687-018-0362-8
Thorough in silico and in vitro cDNA analysis of 21 putative BRCA1 and BRCA2 splice variants and a complex tandem duplication in BRCA2 allowing the identification of activated cryptic splice donor sites in BRCA2 exon 11 Annelot Baert, Eva Machackova et.al.; DOI: 10.1002/humu.23390
